0002109179-26-000001.txt : 20260210 0002109179-26-000001.hdr.sgml : 20260210 20260210153851 ACCESSION NUMBER: 0002109179-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260210 DATE AS OF CHANGE: 20260210 EFFECTIVENESS DATE: 20260210 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Exin Therapeutics, Inc. CENTRAL INDEX KEY: 0002109179 ORGANIZATION NAME: EIN: 384336398 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-573167 FILM NUMBER: 26615673 BUSINESS ADDRESS: STREET 1: 2261 MARKET STREET STE 22614 CITY: SAN FRANCISCO STATE: CA ZIP: 94114 BUSINESS PHONE: (650) 942-3715 MAIL ADDRESS: STREET 1: 2261 MARKET STREET STE 22614 CITY: SAN FRANCISCO STATE: CA ZIP: 94114 D 1 primary_doc.xml X0708 D LIVE 0002109179 Exin Therapeutics, Inc. 2261 MARKET STREET STE 22614 SAN FRANCISCO CA CALIFORNIA 94114 (650) 942-3715 DELAWARE None None Corporation true 2024 Gabriel Ocana Santero 2261 MARKET STREET STE 22614 SAN FRANCISCO CA CALIFORNIA 94114 Executive Officer Director Ivan Alex Priela Lazarte 2261 MARKET STREET STE 22614 SAN FRANCISCO CA CALIFORNIA 94114 Executive Officer Director Marko Tvrdic 2261 MARKET STREET STE 22614 SAN FRANCISCO CA CALIFORNIA 94114 Executive Officer Director Biotechnology Decline to Disclose 06b false 2024-11-18 false true true false 0 2162300 2162300 0 false 28 0 0 0 false Exin Therapeutics, Inc. /S/ Gabriel Ocana Santero Gabriel Ocana Santero Chief Executive Officer 2026-02-10